Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2015

Open Access 01-12-2015 | Poster presentation

P019. Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience

Authors: Antonio Russo, Francesca Conte, Laura Marcuccio, Alfonso Giordano, Gioacchino Tedeschi, Alessandro Tessitore

Published in: The Journal of Headache and Pain | Special Issue 1/2015

Login to get access

Excerpt

Pharmacological anti-migraine preventive therapies are widely used to reduce the impact of migraine on quality of life; nevertheless, they may exhibit incomplete efficacy and significant side effects. Transcutaneous supraorbital neurostimulation (tSNS) has been recently proposed for the treatment of migraine. Moreover, tSNS has been recently found superior to sham stimulation for episodic migraine prevention in a randomized trial [1]. …
Literature
1.
Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, Magis D: Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013, 80 (8): 697-704.CrossRefPubMed
2.
Magis D, Sava S, d'Elia TS, Baschi R, Schoenen J: Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013, 14: 95-PubMedCentralCrossRefPubMed
Metadata
Title
P019. Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience
Authors
Antonio Russo
Francesca Conte
Laura Marcuccio
Alfonso Giordano
Gioacchino Tedeschi
Alessandro Tessitore
Publication date
01-12-2015
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2015
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-16-S1-A136

Other articles of this Special Issue 1/2015

The Journal of Headache and Pain 1/2015 Go to the issue

Oral presentation

O056. Migraine as presenting symptom of SLC20A2gene mutations

Poster presentation

P007. Inhibition of monoacylglycerol lipase activity modulates the activation of brain structures relevant for migraine pathogenesis

Oral presentation

O002. Did Picasso and De Chirico really suffer from migraine auras?

Invited speaker presentation

A proposal for a national registry on chronic migraines

Oral presentation

O027. Sub-cortical sources of the somatosensory pathway are hypoactive in migraine interictally: a Functional Source Separation analysis

Invited speaker presentation

Hemicrania continua and unilateral headaches: are they still together in the IHS classification?